DLBS, along with Dexa Group, joined the Convention on Pharmaceutical Ingredients (CPhI) Worldwide 2014. CPhI is the world's most prestigious pharmaceutical expo and for this year it was held on 7 - 9th of October, 2014, in Paris Nord Villepinte, Paris, France. DLBS was on "Finished Product" zone in Hall 4, with booth number 4K53.

This event was held to give business opportunities to industrial pharmaceutical players and raw material drugs suppliers worldwide. DLBS has been involved in CPhI Worldwide Expo since 2010. In this year, DLBS participated together with Dexa Medica and Ferron Par Pharmaceuticals.

Excellent products by DLBS, created by Indonesian's scientists, were shown at CPhI this year. These products were Inlacin, Dimeno, Redacid and Disolf. Inlacin is indicated for diabetic level 2 patients and pre-diabetic (lowering blood-sugar level). Disolf has a function as anti-thrombosis and thrombolytic. Dismeno is for reducing pain in premenstrual syndrome and endometriosis, while Redacid has indication for gastric ulcer and protection of mucus in the stomach.

Other countries involved in this event were United Kingdom (UK), Russia, Turkey, France, Australia, India, Pakistan, United States, Canada, Romania, and many more. Visitors attending this event were from at least, 22 countries and they looked enthusiastic visiting Dexa Group's Stand. Many questions and discussions about DLBS's products and meetings with potential partners occured at the Dexa Group's Stand.